Braskem BAK
$0.74 −$0.11 (-12.61%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $0.75 +1.56%
Open$0.86
Prev close$0.85
Day range$0.73 – $0.86
Volume962.5K
Market cap$289.52M
P/E (TTM)–
Dividend yield–
Earnings
Average move on report day±4.3%last 16 reports
Closed higher7 of 1644% of the time
Best reaction+20.4%
Worst reaction-10.7%
Stock move on the day after each report
| Quarter | Report date | Timing | Implied move | Actual move | Versus implied |
|---|---|---|---|---|---|
| 2026/Q3 | 12 Nov 2026 | Pre Market | – | +2.73% | – |
| 2026/Q2 | 13 Aug 2026 | Pre Market | – | +1.47% | – |
| 2026/Q1 | 13 May 2026 | After Market | – | -0.20% | – |
| 2025/Q4 | 26 Mar 2026 | None | – | -10.66% | – |
| 2025/Q3 | 10 Nov 2025 | None | – | +20.40% | – |
| 2025/Q2 | 6 Aug 2025 | None | – | -3.49% | – |
| 2025/Q1 | 9 May 2025 | After Market | – | +4.70% | – |
| 2024/Q4 | 26 Feb 2025 | None | – | -3.09% | – |
| 2024/Q3 | 6 Nov 2024 | None | – | -0.49% | – |
| 2024/Q2 | 7 Aug 2024 | Pre Market | – | +4.42% | – |
| 2024/Q1 | 8 May 2024 | After Market | – | -4.39% | – |
| 2023/Q4 | 6 Mar 2024 | None | – | +0.61% | – |
| 2023/Q3 | 9 Nov 2023 | None | – | -0.12% | – |
| 2023/Q2 | 8 Aug 2023 | After Market | – | -2.18% | – |
| 2023/Q1 | 8 May 2023 | After Market | – | +4.57% | – |
| 2022/Q4 | 22 Mar 2023 | After Market | – | -5.70% | – |
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Fundamentals
Latest reported quarter: Q2, ended Jun 2026 · reported in BRL
RevenueR$21.72B+21.6% YoY
Operating profitR$4.00B+518.0% YoY
Net profitR$3.32B+952.1% YoY
Diluted EPSR$8.34+1,345.3% YoY
Free cash flow-R$606.00M+35.3% YoY
Operating cash flowR$29.00M
Revenue, last 8 quarters
Net profit, last 8 quarters
Profitability & balance sheet
Gross margin8.9%
Operating margin6.0%
Net margin-7.8%
Return on assets-6.5%
Current ratio0.77
Liabilities / assets116.5%
Cash & investmentsR$5.93B
Total debtR$67.43B
Net cash (debt)-R$61.50B
No comments yet — be the first to weigh in on BAK.
Sign in to join the discussion.